Page last updated: 2024-08-26

3-methylglutaconic acid and Cochlear Hearing Loss

3-methylglutaconic acid has been researched along with Cochlear Hearing Loss in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duszynski, J; Jurkiewicz, E; Karkucinska-Wieckowska, A; Lebiedzinska, M; Pajdowska, M; Pinton, P; Pronicka, E; Pronicki, M; Suski, J; Szymanska-Debinska, T; Trubicka, J; Wieckowski, MR1
de Koning, T; Engelke, U; Huizing, M; Kluijtmans, LA; Loupatty, FJ; Morava, E; Rodenburg, RJ; Smeitink, JA; Wevers, R; Wortmann, S1

Other Studies

2 other study(ies) available for 3-methylglutaconic acid and Cochlear Hearing Loss

ArticleYear
Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria).
    Folia neuropathologica, 2011, Volume: 49, Issue:1

    Topics: Catalase; Child, Preschool; Deafness; Female; Fibroblasts; Glutarates; Hearing Loss, Sensorineural; Humans; Leigh Disease; Mitochondrial Diseases; Reactive Oxygen Species

2011
Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation.
    Molecular genetics and metabolism, 2006, Volume: 88, Issue:1

    Topics: Adolescent; Brain Diseases, Metabolic; Child; Child, Preschool; Consanguinity; Fatal Outcome; Female; Glutarates; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Leigh Disease; Male; Mitochondrial Diseases; Oxidative Phosphorylation; Syndrome; Valerates

2006